MyEG to be made distributor of Zhifei vaccine


MyEG will be the sole distributor of the vaccine in Malaysia upon successful completion of the phase three trials, it said in a statement.

PETALING JAYA: My E.G. Services Bhd has entered into a memorandum of understanding (MoU) with Anhui Zhifei Longcom Biopharmaceutical Co Ltd to conduct phase three clinical trials and subsequent commercialisation of its Covid-19 vaccine in Malaysia.

MyEG will be the sole distributor of the vaccine in Malaysia upon successful completion of the phase three trials, it said in a statement.

5.5 PAYDAY OFFER: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
MyEG Services , distributor , Zgifei , vaccine ,

Next In Business News

Censuria taps Affin to advance family office plan
How Asia-Pacific is fighting a fuel shock that could get worse
Local equity market remains resilient, reflects investor confidence, says Akmal Nasrullah
Tropicana to acquire Langkawi land for RM195.9mil
Khazanah launches Malaysia’s first tokenised sukuk in RM100mil pilot with SC
7-Eleven unit to acquire Seri Kembangan land for RM19mil
Ringgit closes higher against major, regional currencies
Eco-Shop banks on new outlets for profit growth
Alpha IVF to boost growth with new centres
Bank Islam issues 10th tranche of RM1bil Sukuk Murabahah

Others Also Read